NeuralCipher Source record
Pesticides as hidden modifiers of drug action: Mechanisms and human health implications.
DOI: 10.1016/j.envres.2026.125813PMID: 42810660
A bibliographic record traceable to Europe PMC.
41.000 articles found
Source record
Multipath interaction network of annexin A2: multifaceted regulation and translational perspectives in neurological diseases.
DOI: 10.3389/fgene.2026.1916220PMID: 42861417
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Effects of dual-task training on health-related quality of life and cognitive function in people with Parkinson's disease: a systematic review and meta-analysis.
DOI: 10.3389/fnagi.2026.1939266PMID: 42865648
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Mitochondrial protein import stress in Parkinson's disease: the TOM/TIM-PINK1/Parkin-DELE1/HRI axis linking mitochondrial proteostasis to neuronal death.
DOI: 10.3389/fcell.2026.1935788PMID: 42865685
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Mesenchymal stromal cells in age-related neurodegenerative disorders: mechanisms, translational barriers, and precision strategies.
DOI: 10.3389/fimmu.2026.1965598PMID: 42865955
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Review of levodopa inhalation powder (Inbrija) for Parkinson's disease.
DOI: 10.1136/dtb.2025.000052PMID: 42448455
A bibliographic record traceable to Europe PMC.
Source record
Correction: <i>Review of levodopa inhalation powder (Inbrija) for Parkinson's disease</i>.
DOI: 10.1136/dtb.2025.000052corr1PMID: 42749463
A bibliographic record traceable to Europe PMC.
Source record
Genetic architecture and molecular pathogenesis of Parkinson's disease: emerging mechanisms and therapeutic targets.
DOI: 10.1007/s11011-026-01998-3PMID: 42803978
A bibliographic record traceable to Europe PMC.
Source record
Advances in the management of depression in Parkinson's disease: A narrative review on vortioxetine, hyperbaric oxygen, and physical activity.
DOI: 10.1016/j.biopha.2026.119954PMID: 42805007
A bibliographic record traceable to Europe PMC.
Source record
Oral Environment and Aspiration Pneumonia Risk in Parkinson's Disease: A Narrative Review and Conceptual Framework.
DOI: 10.1111/joor.70326PMID: 42805786
A bibliographic record traceable to Europe PMC.
Source record
Continuous infusion therapy after deep brain stimulation in Parkinson's disease: indications, outcomes, and patient selection.
DOI: 10.1007/s00702-026-03300-2PMID: 42806146
A bibliographic record traceable to Europe PMC.
Source record
Lifestyle medicine for neuroprotection: evidence and implementation in Asian contexts.
DOI: 10.1007/s00702-026-03294-xPMID: 42806148
A bibliographic record traceable to Europe PMC.
Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.